Impact of pharmacist-driven educational intervention and screening assessment tool on vaccination rates at a hospital-based medical residency clinic
Abstract
Background: The goal of this study was to evaluate immunization administration compliance with the Centers for Disease Control (CDC) 2009 immunization recommendations for influenza, pneumococcal, hepatitis A, hepatitis B, tetanus, diphtheria, acellular pertussis (Tdap), and human papillomavirus (HPV) before and after the implementation of pharmacist-driven educational intervention and screening assessment tool.
Methods: Phase 1 of the study included a baseline chart review of patients seen during a 4-week period in 2009. Phase 2 of the study, a review of the charts utilizing the same methods as in phase 1, occurred 15 months after the initiation of a pharmacist driven educational intervention and screening assessment. Rates before and after the intervention were compared to determine improvement in immunization rates. The chart reviews included baseline demographics and patient specific indications for the various vaccines. Compliance with the immunization recommendation was defined as having an indication for the vaccine and receiving at this visit or documentation that the patient received it previously within the appropriate time frame.
Results: A total of 402 patients were included in the analysis. An overall, increase of 8.8% was seen in immunization rates after the implementation of the pharmacist immunization assessment (pre-intervention 21%, post-intervention 29.8%; p <0.001), with a significant increase seen with influenza, hepatitis B, and Tdap vaccines specifically.
Conclusion: The compliance with the CDC immunization recommendations improved with the implementation of a pharmacist driven intervention; however, rates are still low signifying a need for additional educational interventions.Keywords
Full Text:
Subscribers OnlyReferences
Office of Disease Prevention and Health Promotion. Healthy people 2020. Available at: www.healthypeople.gov. Accessed February 18, 2015.
Roush SW, Murphy TV. Vaccine-preventable disease table working group a. historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298:2155-63.
Krishnarajah G, Carroll C, Priest J, et al. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006–2010. Hum Vaccin Immunother[serial online]. 2014;10:2460-67. Accessed February 20, 2015.
Centers of Disease Control and Prevention: Epidemiology and prevention of vaccine preventable diseases. Chapter 3: Immunization strategies for healthcare practices and providers. 11th ed. Atlanta: US Department of Health and Human Services; 2009.
Logan JL. Disparities in influenza immunization among US adults. J Natl Med Assoc 2009;101:161-6.
Ahluwalia IB, Bolen J. Lack of health insurance coverage among working-age adults, evidence from the behavioral risk factor surveillance system, 1993 – 2006. J Community Health 2008;33:293-6.
Office of Disease Prevention and Health Promotion. Healthy people 2010. Available at: www.healthypeople.gov. Accessed February 20, 2015.
ASHP Council on Professional Affairs. ASHP guidelines on the pharmacist’s role in immunizations. Am J Health Syst Pharm 2003;60:1371-4.
Advisory Committee on Immunization Practices. Centers of Disease Control and Prevention: Department of Health and Human Services. Recommended Adult Immunization Schedule, 2009. Available at: www.cdc.gov/vaccines/recs/schedules/downloads/adult/2009/adult-schedule-11x17.pdf. Accessed February 20, 2015.
Williams WW, Lu PJ, O’Halloran A, et al. Noninfluenza vaccination coverage among adults – United States, 2012. MMWR 2014;63:95-102.
Huang SS, Johnson KM, Ray GT, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011; 29: 3398-412.
Tiwari T, Clark TA, Messonnier NE, et al. Tetanus surveillance – United States 2001-2008. MMWR 2011;60;365-9.
Centers of Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women – advisory committee on immunization practices (ACIP), 2012. MMWR 2013;62:131-5.
Fernandez WG, Oyama L, Mitchell P, et al. Attitudes and practices regarding influenza vaccination among emergency department personnel. J Emerg Med 2009;36:201-6.
DOI: http://dx.doi.org/10.18103/imr.v0i2.27
Refbacks
- There are currently no refbacks.